Farallon Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-150,000
| Closed | -$21.9M | – | 174 |
|
|
2023
Q1 | $21.9M | Sell |
150,000
-79,800
| -35% | -$11.7M | 0.12% | 77 |
|
|
2022
Q4 | $36.6M | Sell |
229,800
-307,700
| -57% | -$49M | 0.22% | 69 |
|
|
2022
Q3 | $71.6M | Sell |
537,500
-382,600
| -42% | -$51M | 0.39% | 63 |
|
|
2022
Q2 | $144M | Buy |
920,100
+591,100
| +180% | +$92.2M | 0.78% | 41 |
|
|
2022
Q1 | $51.2M | Sell |
329,000
-102,021
| -24% | -$15.9M | 0.25% | 68 |
|
|
2021
Q4 | $54.9M | Sell |
431,021
-143,886
| -25% | -$18.3M | 0.27% | 62 |
|
|
2021
Q3 | $74.9M | Buy |
+574,907
| New | +$74.9M | 0.35% | 59 |
|